Literature DB >> 11729188

The type IIs restriction endonuclease BspMI is a tetramer that acts concertedly at two copies of an asymmetric DNA sequence.

Niall A Gormley1, Anna L Hillberg, Stephen E Halford.   

Abstract

Type IIs endonucleases recognize asymmetric DNA sequences and cleave both strands at fixed positions downstream of the sequence. Many type IIs enzymes, including BspMI, cleave substrates with two sites more rapidly than those with one site. They usually act sequentially on DNA with two sites, but BspMI converted such a substrate directly to the final products cut at both sites. The BspMI endonuclease was found to be a tetramer, in contrast to the monomeric structures for many type IIs enzymes. No change in subunit association occurred during the BspMI reaction. Plasmids with two BspMI sites were cleaved in cis, in reactions spanning sites in the same DNA, even when the sites were separated by just 38 bp. Plasmids with one BspMI site were cleaved in trans, with the enzyme bridging sites in separate DNA molecules: these slow reactions could be accelerated by adding a second DNA with the recognition sequence. Thus, whereas many type IIs enzymes dimerize before cleaving DNA, a process facilitated by two recognition sites in cis, the BspMI tetramer binds two copies of its recognition sequence before cleaving the DNA in both strands at both sites.

Mesh:

Substances:

Year:  2001        PMID: 11729188     DOI: 10.1074/jbc.M108442200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Functional cooperation between exonucleases and endonucleases--basis for the evolution of restriction enzymes.

Authors:  Nidhanapathi K Raghavendra; Desirazu N Rao
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

2.  DNA supercoiling enables the type IIS restriction enzyme BspMI to recognise the relative orientation of two DNA sequences.

Authors:  Isabel J Kingston; Niall A Gormley; Stephen E Halford
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

3.  Tailoring the activity of restriction endonuclease PleI by PNA-induced DNA looping.

Authors:  Ekaterina Protozanova; Vadim V Demidov; Viatcheslav Soldatenkov; Sergey Chasovskikh; Maxim D Frank-Kamenetskii
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

4.  DNA communications by Type III restriction endonucleases--confirmation of 1D translocation over 3D looping.

Authors:  Luke J Peakman; Mark D Szczelkun
Journal:  Nucleic Acids Res       Date:  2004-08-09       Impact factor: 16.971

5.  One recognition sequence, seven restriction enzymes, five reaction mechanisms.

Authors:  Darren M Gowers; Stuart R W Bellamy; Stephen E Halford
Journal:  Nucleic Acids Res       Date:  2004-06-29       Impact factor: 16.971

6.  A view of consecutive binding events from structures of tetrameric endonuclease SfiI bound to DNA.

Authors:  Eva Scheuring Vanamee; Hector Viadiu; Rebecca Kucera; Lydia Dorner; Stephen Picone; Ira Schildkraut; Aneel K Aggarwal
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

7.  Dynamics of synaptic SfiI-DNA complex: single-molecule fluorescence analysis.

Authors:  Mikhail A Karymov; Alexey V Krasnoslobodtsev; Yuri L Lyubchenko
Journal:  Biophys J       Date:  2007-02-02       Impact factor: 4.033

8.  An EM view of the FokI synaptic complex by single particle analysis.

Authors:  Eva Scheuring Vanamee; John Berriman; Aneel K Aggarwal
Journal:  J Mol Biol       Date:  2007-05-03       Impact factor: 5.469

Review 9.  Imaging of DNA and Protein-DNA Complexes with Atomic Force Microscopy.

Authors:  Yuri L Lyubchenko; Luda S Shlyakhtenko
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2016       Impact factor: 1.807

10.  A putative mobile genetic element carrying a novel type IIF restriction-modification system (PluTI).

Authors:  Feroz Khan; Yoshikazu Furuta; Mikihiko Kawai; Katarzyna H Kaminska; Ken Ishikawa; Janusz M Bujnicki; Ichizo Kobayashi
Journal:  Nucleic Acids Res       Date:  2010-01-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.